What to Avoid When Taking Mesalamine

Mesalamine is one of the most widely prescribed drugs for ulcerative colitis and other inflammatory bowel conditions, and for most people it is well tolerated. But several avoidable mistakes, from mixing it with the wrong medications to storing it improperly, can undermine the drug’s effectiveness or trigger serious side effects. Knowing what to steer clear of while taking mesalamine matters more than you might expect, because some of the risks are not obvious and develop slowly over months or years.

Medications That Interact With Mesalamine

If you take azathioprine or 6-mercaptopurine alongside mesalamine, you face a real risk of a dangerous drop in white blood cells. Mesalamine interferes with the enzyme that breaks down these immunosuppressants, causing their active metabolites to build up in your blood. Research in patients with Crohn’s disease found that adding mesalamine, sulfasalazine, or balsalazide to azathioprine or 6-mercaptopurine raised levels of the active compound (6-thioguanine nucleotides) substantially, producing a high rate of low white cell counts.¹ If your doctor prescribes both drugs, your blood counts should be checked regularly, and the dose of the immunosuppressant may need to be lowered.

Warfarin is another medication to flag. A systematic review of warfarin interactions rated mesalamine as a “highly probable” inhibitor of warfarin’s anticoagulant effect, meaning it could reduce how well the blood thinner works.² If you take warfarin and start mesalamine, your INR (the measure of how thin your blood is) should be rechecked, because it may drift lower than expected.

Alcohol also deserves a mention. A review of alcohol’s impact on inflammatory bowel disease medications noted that mesalamine’s effectiveness can be affected by alcohol intake through several pathways.³ Beyond any direct drug interaction, alcohol is a known gut irritant that can trigger or worsen flares in ulcerative colitis on its own, so heavy drinking works against everything mesalamine is trying to do.

How Food Affects Different Mesalamine Formulations

One of the trickiest things about mesalamine is that “take it with food” or “take it on an empty stomach” depends entirely on which version of the drug you have been prescribed. Mesalamine comes in multiple formulations, each engineered to release the active ingredient at a specific point in your digestive tract. Food changes the speed and acidity of digestion, which means it changes where the drug dissolves.

For certain extended-release capsules (like Apriso) and delayed-release tablets (like Lialda), eating, particularly a high-fat meal, causes more of the drug to release earlier in the gut, before it reaches the colon where it is needed. Lab testing showed that under simulated fed-state conditions, roughly a fifth of the drug in Apriso capsules released prematurely, and Lialda tablets released about four and a half times more drug in fed versus fasted conditions.⁴ That premature release means more mesalamine gets absorbed into your bloodstream systemically rather than acting locally in the colon, which both reduces effectiveness and raises the chance of side effects.

Not every formulation behaves this way. Pentasa extended-release capsules and Asacol HD delayed-release tablets showed no meaningful difference in drug release between fed and fasted states in the same study.⁴ This was supported by separate biorelevant modeling, which predicted minimal changes in proximal gut release for Asacol, Mezavant (the European equivalent of Lialda, though the modeling found it stable), Pentasa, and Salofalk 500 mg under fed conditions.⁵

A study in healthy volunteers taking enteric-coated mesalamine tablets found that food, especially high-fat meals, significantly delayed absorption, leading the researchers to recommend taking those tablets before meals.⁶ The bottom line is that you should read the instructions that come with your specific product and confirm with your pharmacist whether to take it with food or not. Treating all mesalamine the same is a common mistake that can compromise how well the drug works.

Protecting Your Kidneys

Kidney damage is probably the most serious long-term risk of mesalamine that too few patients know about. The drug can cause a type of inflammation in the kidneys called interstitial nephritis, and the danger is that it often develops gradually without obvious symptoms. If caught early and the drug is stopped, the damage is usually reversible. But if it goes undetected, prolonged exposure can lead to irreversible kidney failure and even end-stage kidney disease requiring dialysis.⁷

This is not just theoretical. Case reports consistently show that mesalamine-induced interstitial nephritis happens often enough to warrant routine monitoring, and no convincing evidence supports treating it with corticosteroids once it develops.⁷ The only reliable intervention is stopping the drug. Clinical guidelines recommend frequent monitoring of serum creatinine, especially in the first few years after starting mesalamine. If your doctor has not been checking your kidney function periodically, it is worth bringing up at your next appointment. A case report and clinical review reinforced this, concluding that regular urine testing and creatinine monitoring during mesalamine treatment are essential to prevent irreversible kidney damage.⁸

Kidney Stones and Staying Hydrated

Separate from the interstitial nephritis issue, people with inflammatory bowel disease already have about twice the normal risk of developing kidney stones.⁹ Several factors stack against you: chronic diarrhea reduces urine output, bicarbonate loss makes your urine more acidic, and poor absorption of stone-inhibiting substances like citrate and magnesium makes stone formation more likely.⁹ Mesalamine itself has also been reported as a rare direct cause of kidney stones.

The practical advice is straightforward: stay well hydrated. This sounds generic, but for mesalamine users with active bowel disease who may already be losing fluid through diarrhea, dehydration is both more common and more consequential. Drinking enough to keep your urine light-colored is a simple, evidence-backed way to lower your stone risk.

Recognizing Mesalamine Intolerance Early

A small but significant percentage of patients actually become intolerant to mesalamine itself, and the symptoms can look frustratingly similar to an ulcerative colitis flare, which makes it easy to miss. In a retrospective study of patients who developed mesalamine intolerance, about half showed symptoms within the first two weeks of starting the drug, and roughly three-quarters experienced them within the first month.¹⁰

The most common intolerance symptoms were fever (about 84% of cases), abdominal pain, diarrhea, and bloody stool (around 74% and 71%, respectively).¹⁰ You can see the problem: if you just started mesalamine for ulcerative colitis and then develop worsening diarrhea and abdominal pain, the natural assumption is that your disease is getting worse, not that the treatment is the culprit. Fever is a useful clue. Ulcerative colitis flares can cause a low-grade fever, but a high fever shortly after starting mesalamine, particularly if your inflammatory markers spike, should prompt your gastroenterologist to consider intolerance as the cause rather than simply escalating the dose.

Aspirin Sensitivity and Mesalamine

People who are allergic or sensitive to aspirin sometimes worry about taking mesalamine because its chemical name, 5-aminosalicylic acid, sounds similar to acetylsalicylic acid (aspirin). Despite the name resemblance, the two molecules are chemically distinct, and the evidence for true cross-reactivity is thin. A review of available data found a “dearth of evidence” demonstrating cross-reactivity between aspirin or other NSAIDs and mesalamine.¹¹

That said, the review recommended that patients with known aspirin or NSAID sensitivity who need mesalamine should receive a supervised test dose to rule out any rare cross-reaction, or undergo further investigation of their aspirin sensitivity before starting treatment.¹¹ So the answer is not “absolutely avoid mesalamine if you’re aspirin-sensitive.” It is “don’t skip it automatically, but don’t take it unsupervised without confirming it’s safe for you.”

Liver Function and Mesalamine

Mesalamine was originally developed as the active ingredient in sulfasalazine without the sulfa component, partly in the hope that it would have fewer side effects. That turned out to be mostly true, but not entirely. Research found that mesalamine can cause many of the same adverse effects as sulfasalazine, including liver problems, and that liver-related side effects may be nearly as common as with the older drug.¹²

In reported cases, continued mesalamine use after liver dysfunction appeared led to chronic hepatitis and liver fibrosis. The researchers concluded that when liver dysfunction occurs, mesalamine should be discontinued to prevent progression to chronic liver disease.¹² The takeaway: if your blood tests show rising liver enzymes while you are on mesalamine, do not ignore it or assume it is unrelated. Liver function panels should be part of routine monitoring alongside the kidney checks discussed earlier.

Sun Exposure and Skin Reactions

Mesalamine has been associated with photosensitivity, meaning your skin may react more severely to sunlight than it normally would. Along with general skin rashes and itching, case reports have documented patients developing significant sunburn-like reactions at sun exposures that previously caused them no trouble.¹³ This side effect is not extremely common, but if you notice that you are burning more easily or developing unexplained rashes on sun-exposed skin after starting mesalamine, the drug could be responsible. Standard sun-protection measures, including sunscreen, hats, and limiting midday exposure, are reasonable precautions while on the medication.

Tablets Passing Through Intact

If you take a multi-matrix system (MMX) formulation of mesalamine and notice what looks like an intact tablet in your stool, you are not imagining things and you are not alone. Research into this phenomenon found that MMX mesalamine is often excreted intact, meaning the tablet passes through without fully dissolving, and this increases the risk of relapse because you effectively received a lower dose than prescribed.¹⁴

This is particularly worth watching for if your disease seems to be worsening despite good adherence. Some patients and even some doctors assume the drug is not working and escalate to stronger therapies, when in reality the tablet is just not dissolving properly. If you consistently find intact-looking tablets in your stool, raise this with your gastroenterologist. Switching to a different mesalamine formulation, such as granules or a different release mechanism, can sometimes solve the problem without changing the active drug.

Pregnancy and Breastfeeding

For people of childbearing age with inflammatory bowel disease, one of the biggest concerns is whether mesalamine is safe during pregnancy. The evidence here is reassuring. Expert consensus, supported by safety data, considers 5-aminosalicylates (the class mesalamine belongs to) safe for use during pregnancy.¹⁵ Uncontrolled bowel inflammation during pregnancy carries its own risks to both mother and baby, so stopping mesalamine out of vague caution can actually be worse than continuing it.

That does not mean you should make any medication changes on your own during pregnancy. But if you find out you are pregnant while taking mesalamine, the current expert view is that you should not panic or abruptly stop the drug. Discuss it with your gastroenterologist and obstetrician, but expect that in most cases, they will advise continuing treatment. The drugs that genuinely need to be avoided during pregnancy in IBD are different ones, particularly methotrexate and tofacitinib.¹⁵

Storing Mesalamine Properly

Heat is mesalamine’s worst enemy outside the body. Stability testing showed that when pure mesalamine was exposed to 80°C (about 176°F) dry heat for 24 hours, the drug degraded completely, with the original compound entirely breaking down into degradation products.¹⁶ While 80°C is far hotter than a typical room, this extreme sensitivity to heat means everyday scenarios like leaving your medication in a hot car during summer, in direct sunlight on a windowsill, or in a steamy bathroom can meaningfully degrade the drug over time.

The practical rule is to store mesalamine at room temperature, in a dry place, away from heat and direct light. If you travel frequently, keep the medication in a climate-controlled bag rather than a checked suitcase that might sit on a hot tarmac. A pill that looks fine on the outside may have lost potency if it has been through repeated heat exposure, and you would have no way of knowing until your symptoms started creeping back.

When Monitoring Matters Most

If there is a single overarching theme across the risks described here, it is that the most avoidable harms from mesalamine come from lack of monitoring rather than from the drug itself. Kidney damage is preventable if creatinine is checked regularly. Liver problems are manageable if caught before they progress. Mesalamine intolerance is identifiable within the first month if doctors and patients are watching for it rather than assuming worsening symptoms mean worsening disease. The drug interactions with azathioprine and warfarin are well-characterized and manageable with blood tests.

Ask your doctor specifically about their monitoring schedule for kidney and liver function. If you are starting mesalamine for the first time, pay close attention to how you feel in the first two to four weeks, particularly to any new fever. Keep your specific formulation’s food instructions on hand, stay hydrated, and store the medication properly. None of these steps are difficult, but each one meaningfully reduces the chance that a generally safe and effective drug causes you an avoidable problem.

1
Gut. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
2
JAMA Internal Medicine. Systematic Overview of Warfarin and Its Drug and Food Interactions
3
PubMed. The Impact of Alcohol in Inflammatory Bowel Diseases
4
Journal of Drug Delivery Science and Technology. Effect of postprandial gastric conditions on in vitro drug release from modified release mesalamine formulations
5
PubMed. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release
6
PubMed. Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers
7
PubMed. The Association of Mesalamine With Kidney Disease
8
Acta medica Lituanica. Drug-Induced Intersticial Nephritis. Clinical Case
9
PubMed Central. Mesalazine-induced renal calculi
10
PubMed Central. Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
11
PubMed Central. Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs
12
PubMed Central. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
13
PubMed Central. Mesalamine-induced photosensitivity – A case report and literature review
14
PubMed Central. The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis
15
PubMed. Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis
16
PubMed Central. Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products